---
title: "Morgan Stanley Remains a Buy on Integral Diagnostics Ltd. (IDX)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297468614.md"
description: "In a report released today, David Bailey from Morgan Stanley maintained a Buy rating on Integral Diagnostics Ltd., with a price target of A$3.70. According to TipRanks, Bailey is a 4-star analyst with an average return of 9.4% and a 52.63% success rate. Bailey covers the Healthcare sector, focusing on stocks such as Integral Diagnostics Ltd., Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, and Resmed. Integral Diagnostics Ltd. has an analyst consensus of Strong Buy, with a price target consensus of A$3.14."
datetime: "2026-08-31T05:55:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297468614.md)
  - [en](https://longbridge.com/en/news/297468614.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297468614.md)
generator: "portal-rs"
---

# Morgan Stanley Remains a Buy on Integral Diagnostics Ltd. (IDX)

In a report released today, David Bailey from Morgan Stanley maintained a Buy rating on Integral Diagnostics Ltd., with a price target of A$3.70.

According to TipRanks, Bailey is a 4-star analyst with an average return of 9.4% and a 52.63% success rate. Bailey covers the Healthcare sector, focusing on stocks such as Integral Diagnostics Ltd., Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, and Resmed.

Integral Diagnostics Ltd. has an analyst consensus of Strong Buy, with a price target consensus of A$3.14.

### Related Stocks

- [IDX.AU](https://longbridge.com/en/quote/IDX.AU.md)
- [RMD.US](https://longbridge.com/en/quote/RMD.US.md)
- [RMD.AU](https://longbridge.com/en/quote/RMD.AU.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)

## Related News & Research

- [Saudi Central Bank Increases Position in ResMed Inc. $RMD](https://longbridge.com/en/news/298289532.md)
- [ResMed director Peter C. Farrell disposes of 970 common shares worth $227,688.10](https://longbridge.com/en/news/298025395.md)
- [Shaw and Partners Keeps Their Buy Rating on Polymetals Resources Ltd. (POL)](https://longbridge.com/en/news/298422932.md)
- [Macquarie Keeps Their Hold Rating on Region Group (SCPAF)](https://longbridge.com/en/news/298185411.md)
- [Macquarie Reaffirms Their Buy Rating on Megaport (MGPPF)](https://longbridge.com/en/news/298158915.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**